Position in OBIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$242,464
-$94,072 QoQ
Shares Held
56,191
-29.0% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 77 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OBIO Over Time
Shares Held
Position Value (USD)
Derivatives in OBIO
reported options exposure · as of Jun 30, 2026CallValue
$52,211
CallShares
12,100
PutValue
$75,944
PutShares
17,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,086,778,995 across 435 Biotechnology names. OBIO ranks #305 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in OBIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,211 | 12,100 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $75,944 | 17,600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $242,464 | 56,191 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $336,536 | 79,185 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $68,890 | 16,600 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $100,430 | 24,200 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $125,226 | 30,175 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $133,924 | 54,002 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $132,501 | 49,441 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $87,654 | 20,480 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $49,116 | 12,279 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $103,391 | 20,115 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $92,322 | 10,112 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,486,071 | 170,421 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,192,947 | 170,421 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,335,138 | 170,421 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 HSAQ | — | 170,458 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 HSAQ | — | 171,808 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 HSAQ | — | 250,968 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 HSAQ | — | 261,594 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 HSAQ | — | 263,281 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 HSAQ | — | 259,824 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 HSAQ | — | 255,439 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 HSAQ | — | 259,090 | Shares | Defined | 2021-05-21 | |
| 2020-12-31 HSAQ | — | 250,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 HSAQ | — | 250,000 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||